MXC Capital Limited First Investment into Joint Venture with Liberty Global

MXC Capital Limited ORD NPV
[shareaholic app="share_buttons" id_name="post_below_content"]

MXC Capital Limited (LON:MXCP), the technology focused adviser and investor, has today announced that it has made its first investment into MXLG Acquisitions Limited (“MXLG”), its joint venture with Liberty Global Europe 2 Limited (“LGE2”) (a wholly owned subsidiary of Liberty Global plc (“Liberty Global”)).

This investment has enabled MXLG to complete its first acquisition, SICL Limited (“SICL”), a Leeds based, award winning IT infrastructure and network specialist providing a range of on-premises, cloud and hybrid technological solutions and services to its customer base (the “Acquisition”).

MXC, together with a co-investor, have each made an equity investment of £2.35 million into MXC JV Limited (“MXCJV”) to part fund the Acquisition (the “Investment”).

Following the Investment, MXC holds 100% of the voting rights of MXCJV and owns 50% of its issued share capital. MXCJV holds 50% of the issued share capital of MXLG with LGE2 owning the remaining 50%.

Ian Smith, CEO of MXC Capital Limited, commented: “I am pleased to be able to announce the first acquisition by our joint venture with Liberty Global. SICL represents the first step in MXLG’s strategy of building an IT services provider focused on small and medium sized business customers within the UK. We are excited to have commenced this journey.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Argent BioPharma Ltd, formerly MGC Pharmaceuticals Limited, is a pioneering drug discovery company in the biopharmaceutical sector. Learn about their recent name change and impactful advancements in drug development.

      Search

      Search